David Laffer’s 2011 Pharmacy Killings Exposed Opioid Crisis After 4 Murders for Pain Pills
Updated
Updated · Newsday · Jun 19
David Laffer’s 2011 Pharmacy Killings Exposed Opioid Crisis After 4 Murders for Pain Pills
1 articles · Updated · Newsday · Jun 19
Summary
Fifteen years after David Laffer killed four people at Medford’s Haven Drugs, the case is being recast as a turning point that exposed how opioid addiction could drive extreme violence.
Thousands of stolen pain pills—not cash or valuables—were the target, and investigators later found Laffer and his wife had obtained nearly 12,000 pills in four years, including more than 2,500 from a Queens doctor.
Laffer pleaded guilty to first-degree murder and is serving life without parole; getaway driver Melinda Brady got 25 years, while Dr. Stan Li was convicted over illegal prescribing and died in prison in 2020.
The killings helped accelerate New York’s opioid crackdown, including the I-STOP prescription-monitoring law and a 2016 ban on handwritten opioid scripts.
Experts say overdose deaths on Long Island have fallen in recent years, but a delayed expansion of treatment after pill-supply restrictions pushed some users toward heroin and fentanyl.
A massacre for pills sparked a crackdown. Fifteen years later, has this only fueled a deadlier fentanyl crisis on the streets?
With marijuana being federally rescheduled, what lessons from the 2011 opioid crackdown should shape today's national drug policies?
Turning Point in the Opioid Crisis: The 2011 Medford Pharmacy Shooting and Its Ripple Effects on New York State Policy
Overview
Over a decade after the opioid crisis began, its impact still shapes public health and policy in New York State. Suffolk County led the way by suing opioid manufacturers and distributors, resulting in settlements to address the crisis’s damage. New York has also evolved its public health strategies, such as creating the Office of Community Safety and supporting harm reduction programs like N-CAP to make naloxone more accessible. Despite these efforts, challenges remain, especially in ensuring opioid settlement funds are used effectively. The ongoing struggle highlights the need for continued, comprehensive action to support affected communities.